Yilmaz İ - Search Results

1

GINA step 1-2 therapy: Low-dose ICSformoterol combination taken as needed or moderate-dose ICS-formoterol combination taken as needed?

Yilmaz İ, Türk M. Yilmaz İ, et al. Tuberk Toraks. 2024 Dec;72(4):316-317. doi: 10.5578/tt.2024041003. Tuberk Toraks. 2024. PMID: 39745232 Free article. No abstract available.

2

Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients.

Türk M, Yılmaz İ, Bahçecioğlu SN. Türk M, et al. Among authors: yilmaz i. Allergol Int. 2018 Jan;67(1):85-89. doi: 10.1016/j.alit.2017.05.003. Epub 2017 May 26. Allergol Int. 2018. PMID: 28566225 Free article.

3

What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?

Yilmaz I, Turk M. Yilmaz I, et al. Am J Respir Crit Care Med. 2017 Nov 1;196(9):1229-1230. doi: 10.1164/rccm.201705-0892LE. Am J Respir Crit Care Med. 2017. PMID: 28650681 No abstract available.

4

Classification of eosinophilic granulomatosis with polyangiitis phenotypes and treatment based on phenotypes.

Yılmaz İ, Türk M, Bahçecioğlu SN. Yılmaz İ, et al. Autoimmun Rev. 2017 Sep;16(9):992-993. doi: 10.1016/j.autrev.2017.07.010. Epub 2017 Jul 13. Autoimmun Rev. 2017. PMID: 28711579 No abstract available.

5

Is nonhomogeneous expression of tissue mast cells or allergen specific IgEs bound to tissue mast cells possible?

Türk M, Bahçecioğlu SN, Yılmaz İ. Türk M, et al. Among authors: yilmaz i. Asia Pac Allergy. 2017 Jul;7(3):179-181. doi: 10.5415/apallergy.2017.7.3.179. Epub 2017 Jul 26. Asia Pac Allergy. 2017. PMID: 28765824 Free PMC article.

6

Comment on: "Targeting the PGD₂/CRTH₂/DP₁ Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives".

Yılmaz İ, Türk M. Yılmaz İ, et al. Drugs. 2017 Nov;77(17):1925-1926. doi: 10.1007/s40265-017-0821-2. Drugs. 2017. PMID: 28975564 No abstract available.

7

Eosinophilic asthma with nasal polyposis march: Is aspirin-exacerbated respiratory disease the last station?

Yılmaz İ, Türk M, Bahçecioğlu SN. Yılmaz İ, et al. J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1807-1808. doi: 10.1016/j.jaip.2017.07.048. J Allergy Clin Immunol Pract. 2017. PMID: 29122169 No abstract available.

8

Successful rapid subcutaneous desensitization to anakinra in a case with a severe immediate-type hypersensitivity reaction.

YIlmaz I, Türk M, Nazik Bahçecioğlu S. YIlmaz I, et al. Eur Ann Allergy Clin Immunol. 2018 Mar;50(2):94-96. doi: 10.23822/EurAnnACI.1764-1489.30. Epub 2017 Nov 22. Eur Ann Allergy Clin Immunol. 2018. PMID: 29384104 Free article.

9

Ranitidine-Induced Anaphylaxis in a Patient with Acute COPD Exacerbation.

Yılmaz İ, Türk M. Yılmaz İ, et al. Turk Thorac J. 2017 Jul;18(3):94-95. doi: 10.5152/TurkThoracJ.2017.17002. Epub 2017 Jul 1. Turk Thorac J. 2017. PMID: 29404169 Free PMC article.

10

Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria.

Türk M, Kocatürk E, Cüre K, Yılmaz İ. Türk M, et al. Among authors: yilmaz i. J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1389-1390. doi: 10.1016/j.jaip.2018.01.027. Epub 2018 Feb 2. J Allergy Clin Immunol Pract. 2018. PMID: 29410306 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters